Related Experiment Video
Updated: Jan 11, 2026
09:02
Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024
3.0K
Deciphering Novel Molecular Targets in Neuro-Oncology: An Update
Kanishka Alagar Raja1, Kunnathur Murugesan Sakthivel2, Venugopal Vinod Prabhu3
1Apex Research and Scientific Writing Academy, Cary, NC 27707, USA.
Summary
Neuro-oncology research focuses on brain and spinal cord tumors. Targeting molecular pathways in cancer offers personalized therapies, improving patient outcomes and driving precision medicine innovation.
Area of Science:
- Neuro-oncology
- Molecular Biology
- Cancer Research
Background:
- Neuro-oncology studies brain and spinal cord neoplasms.
- Molecular targets and signaling pathways are crucial for personalized medicine.
- Signaling pathways regulate vital cellular processes but are often dysregulated in cancer.
Purpose of the Study:
- To highlight the importance of molecular targets and signaling pathways in neuro-oncology.
- To emphasize the role of these pathways in personalized cancer therapies.
- To underscore the shift towards precision medicine in cancer treatment.
Main Methods:
- Review of current research in neuro-oncology.
- Analysis of the role of molecular targets and signaling pathways in cancer development.
- Examination of the impact of targeted therapies on patient outcomes.
Main Results:
- Targeting dysregulated signaling pathways leads to personalized therapies.
- Personalized therapies improve treatment efficacy and reduce side effects.
- This approach significantly enhances patient outcomes and minimizes toxicity.
Conclusions:
- The integration of molecular targets and signaling pathways is vital for advancing neuro-oncology.
- Personalized medicine driven by molecular insights improves cancer care.
- Continued research in this area drives innovation in drug discovery and patient treatment.
Related Concept Videos
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
01:26Targets for Drug Action: Overview
10.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.0K
02:56Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
02:49Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
543
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
543
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K